G
Gerard J. Canny
Researcher at Boston Children's Hospital
Publications - 47
Citations - 3425
Gerard J. Canny is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Asthma & Pulmonary function testing. The author has an hindex of 25, co-authored 47 publications receiving 3303 citations. Previous affiliations of Gerard J. Canny include Trinity College, Dublin & University College Dublin.
Papers
More filters
Journal ArticleDOI
Prediction of mortality in patients with cystic fibrosis.
TL;DR: Patients with cystic fibrosis should be considered candidates for lung transplantation when the FEV1 falls below 30 percent of the predicted value, and female patients and younger patients may need to be considered for transplantation at an earlier stage.
Journal ArticleDOI
A randomized controlled trial of a 3-year home exercise program in cystic fibrosis
Jane Schneiderman-Walker,Susan L. Pollock,Mary Corey,Donna D. Wilkes,Gerard J. Canny,Linda Pedder,J. Reisman +6 more
TL;DR: Consistent compliance with the home exercise program and a self-reported positive attitude toward exercise provide further evidence of the feasibility and value of including an aerobic exercise program in the conventional treatment regimen of patients with CF.
Journal ArticleDOI
Energy expenditure of patients with cystic fibrosis.
TL;DR: It is concluded that resting energy expenditure in patients with cystic fibrosis exceeds normal values and that the increase correlates with a deterioration in lung function and nutritional status.
Journal ArticleDOI
A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma
Suzanne Schuh,J. Reisman,Mohammed Alshehri,Annie Dupuis,Mary Corey,Rita Arseneault,Ghassan A. Alothman,Olwen Tennis,Gerard J. Canny +8 more
TL;DR: Children with severe acute asthma should be treated with oral prednisone and not with inhaled fluticasone or a similar inhaled corticosteroid, according to this double-blind, randomized trial.
Journal ArticleDOI
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma.
Eitan Kerem,Henry Levison,Suzanne Schuh,Hugh O'Brodovich,J. Reisman,Lea Bentur,Gerard J. Canny +6 more
TL;DR: It is concluded that spacers and nebulizers are equally effective means of delivering beta 2-agonists to children with acute asthma.